Compounds > 3,3'-diindolylmethane
Page last updated: 2024-10-26

3,3'-diindolylmethane and HPV Infection

3,3'-diindolylmethane has been researched along with HPV Infection in 3 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sepkovic, DW2
Stein, J2
Carlisle, AD2
Ksieski, HB2
Auborn, K2
Bradlow, HL2
Raucci, L1
Nyirenda, T1
Lorincz, AT1
Brentnall, AR1
Vasiljević, N1
Scibior-Bentkowska, D1
Castanon, A1
Fiander, A1
Powell, N1
Tristram, A1
Cuzick, J1
Sasieni, P1

Trials

1 trial available for 3,3'-diindolylmethane and HPV Infection

ArticleYear
HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.
    International journal of cancer, 2013, Aug-01, Volume: 133, Issue:3

    Topics: Capsid Proteins; Cervix Uteri; Colposcopy; DNA Methylation; DNA, Viral; Female; Human papillomavirus

2013

Other Studies

2 other studies available for 3,3'-diindolylmethane and HPV Infection

ArticleYear
Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:11

    Topics: Animals; Anticarcinogenic Agents; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Immunity; In

2009
Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:6

    Topics: Animals; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans;

2011